Cargando…
Myasthenia gravis associated with novel coronavirus 2019 infection: A report of three cases
Several neurological presentations have been reported following coronavirus 2019 (COVID-19) infection. This case report describes three myasthenia gravis (MG) patients presented following COVID-19 infection. We report three adult patients with myasthenic Gravis and COVID-19 infection. The patients a...
Autores principales: | Karimi, Narges, Okhovat, Ali Asghar, Ziaadini, Bentolhoda, Haghi Ashtiani, Bahram, Nafissi, Shahriar, Fatehi, Farzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299214/ https://www.ncbi.nlm.nih.gov/pubmed/34329810 http://dx.doi.org/10.1016/j.clineuro.2021.106834 |
Ejemplares similares
-
A retrospective study of the safety and efficacy of rituximab in Iranian patients with myasthenia gravis: A single-center experience
por: Ziaadini, Bentolhoda, et al.
Publicado: (2022) -
Guillain-Barre syndrome in patients with coronavirus disease-2019: Report of six cases and review of literature
por: Okhovat, Ali Asghar, et al.
Publicado: (2020) -
Validation of myasthenia gravis activity of daily living questionnaire: Persian version
por: Faghani, Shahriar, et al.
Publicado: (2022) -
Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab Biosimilar
por: Fatehi, Farzad, et al.
Publicado: (2021) -
Cholinergic neuromuscular hyperactivity in a patient with anti-muscle-specific tyrosine kinase myasthenia gravis
por: Okhovat, Ali Asghar, et al.
Publicado: (2020)